Stablepoint Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Buy |
166,735
+5,615
| +3% | +$136K | 0.69% | 53 |
|
|
2025
Q1 | $4.08M | Buy |
161,120
+29,249
| +22% | +$741K | 0.74% | 52 |
|
|
2024
Q4 | $3.5M | Sell |
131,871
-3,717
| -3% | -$98.6K | 0.64% | 54 |
|
|
2024
Q3 | $3.92M | Buy |
135,588
+1,032
| +0.8% | +$29.9K | 0.72% | 54 |
|
|
2024
Q2 | $4.13M | Buy |
134,556
+33,529
| +33% | +$1.03M | 0.8% | 50 |
|
|
2024
Q1 | $2.8M | Buy |
101,027
+10,130
| +11% | +$281K | 0.57% | 60 |
|
|
2023
Q4 | $2.62M | Buy |
+90,897
| New | +$2.62M | 0.67% | 54 |
|